Negative Second PET-CT 1 Year After Treatment of Oropharyngeal Cancer Predicts Low Mortality and Recurrence
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.A second PET-CT scan one year after oropharyngeal cancer treatment accurately predicts survival. No evidence of disease on this scan indicates very low recurrence and mortality rates.
Area Of Science
- Oncology
- Nuclear Medicine
- Radiology
Background
- Oropharyngeal carcinoma (OPC) treatment often involves complex follow-up protocols.
- Early detection of recurrence is crucial for improving patient outcomes.
Purpose Of The Study
- To evaluate the predictive value of a second PET-CT scan performed one year after treatment for OPC.
- To assess the association of one-year post-treatment PET-CT findings with long-term survival and recurrence rates.
Main Methods
- Retrospective study of 77 OPC patients treated between 2010-2020.
- All patients underwent two post-treatment PET-CT scans: one at 3 months and a second at 1 year.
- Follow-up extended to 5 years, with overall survival (OS) and disease-free survival (DFS) as primary outcomes.
Main Results
- 65% of patients showed no evidence of disease (NED) on the 1-year PET-CT.
- The 1-year PET-CT had a 91% negative predictive value for 4-year DFS and 100% for 4-year OS.
- NED on the 1-year PET-CT strongly correlated with 5-year DFS (OR 55) and low recurrence probability (OR 11.23).
Conclusions
- No evidence of disease on a 1-year post-treatment PET-CT for OPC signifies minimal risk of recurrence and mortality.
- A negative 1-year PET-CT, following a negative 3-month scan, may support less intensive clinical follow-up.
- This imaging modality offers valuable prognostic information for oropharyngeal cancer survivors.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.